Word

EPISCREEN

Status

Registered

Status Code

704

Status Date

Saturday, September 30, 2023

Serial Number

86716415

Registration Number

5093688

Registration Date

Tuesday, December 6, 2016

Mark Type

4000

Filing Date

Thursday, August 6, 2015

Published for Opposition

Tuesday, June 28, 2016

Trademark Owner History

ABZENA (UK) LIMITED -
Polytherics Limited - Original Registrant

Classifications

5 [ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; vaccines; pharmaceutical preparations for skin care ]

44 Medical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins

42 Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development

Trademark Events

Sep 30, 2023

Notice Of Acceptance Of Sec. 8 - E-Mailed

Sep 30, 2023

Registered - Partial Sec. 8 (6-Yr) Accepted

Sep 22, 2023

Teas Response To Office Action-Post Reg Received

Jun 2, 2023

Post Registration Action Mailed - Sec. 8

Jun 2, 2023

Case Assigned To Post Registration Paralegal

Dec 2, 2022

Teas Section 8 Received

Dec 6, 2021

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jul 31, 2019

Automatic Update Of Assignment Of Ownership

Dec 6, 2016

Registered-Principal Register

Oct 31, 2016

1(B) Basis Deleted; Proceed To Registration

Oct 11, 2016

Notice Of Allowance Cancelled

Oct 30, 2016

Case Assigned To Intent To Use Paralegal

Oct 11, 2016

Teas Post Publication Amendment Received

Aug 23, 2016

Noa E-Mailed - Sou Required From Applicant

Jun 28, 2016

Official Gazette Publication Confirmation E-Mailed

Jun 28, 2016

Published For Opposition

Jun 8, 2016

Notification Of Notice Of Publication E-Mailed

May 20, 2016

Law Office Publication Review Completed

May 13, 2016

Approved For Pub - Principal Register

May 5, 2016

Teas/Email Correspondence Entered

May 5, 2016

Correspondence Received In Law Office

Apr 28, 2016

Assigned To Lie

Apr 15, 2016

Teas Response To Office Action Received

Nov 19, 2015

Notification Of Non-Final Action E-Mailed

Nov 19, 2015

Non-Final Action E-Mailed

Nov 19, 2015

Non-Final Action Written

Nov 18, 2015

Assigned To Examiner

Aug 11, 2015

New Application Office Supplied Data Entered

Aug 10, 2015

New Application Entered